Ono Pharmaceutical Co Stock Investor Sentiment

OPHLF Stock  USD 9.60  1.07  10.03%   
Roughly 61% of Ono Pharmaceutical's investor base is looking to short. The analysis of overall sentiment of trading Ono Pharmaceutical Co pink sheet suggests that many investors are alarmed at this time. The current market sentiment, together with Ono Pharmaceutical's historical and current headlines, can help investors time the market. In addition, many technical investors use Ono Pharmaceutical stock news signals to limit their universe of possible portfolio assets.
Ono Pharmaceutical pink sheet news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Ono daily returns and investor perception about the current price of Ono Pharmaceutical Co as well as its diversification or hedging effects on your existing portfolios.
  
over a year ago at news.google.com         
Cue Biopharma, Inc. Q2 2023 Earnings Call ... - Insider Monkey
Google News at Macroaxis
over a year ago at news.google.com         
Repare Therapeutics Provides Business Update and Reports ... - Financial Post
Google News at Macroaxis
over a year ago at news.google.com         
Personalis Reports Second Quarter 2023 Financial Results - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
PARP Inhibitor Market Gaining a Strong Foothold 2030 ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Ono Pharmaceutical Co. Ltd - ADR Price Target ... - msnNOW
Google News at Macroaxis
over a year ago at news.google.com         
Equillium Announces 7.5 Million Share Repurchase Program - Business Wire
Google News at Macroaxis
over a year ago at news.google.com         
PD-1 Antibody Drug Market Share and Ongoing Trends, Size ... - University City Review
Google News at Macroaxis
over a year ago at news.google.com         
Stomach Cancer Drugs Market Growth, Production, Suppliers ... - Digital Journal
Google News at Macroaxis
over a year ago at news.google.com         
Bristol Myers sales fall, cuts 2023 forecast as drugs face competition - Reuters
Google News at Macroaxis
over a year ago at news.google.com         
BRIEFOno and BMS settle over lawsuits on PD-L1 and CTLA-4 ... - The Pharma Letter
Google News at Macroaxis
over a year ago at news.google.com         
Global Acute Agitation And Aggression Treatment Market Size and ... - Glasgow West End Today
Google News at Macroaxis
over a year ago at news.google.com         
ONO and AIXs Jointly Developed an AI System for Topic Extraction Analysis of Medical Articles - Mark...
Google News at Macroaxis
over a year ago at news.google.com         
Narcolepsy Market expected to rise by 2032 Companies Axsome Therapeutics, Inc., Avadel Pharmaceutica...
Google News at Macroaxis
over a year ago at news.google.com         
Viscosupplementation Market Share, Trends, Size, Growth Forecast 2023-2028 - openPR
Google News at Macroaxis
over a year ago at news.google.com         
Bristol Myers Squibb Receives European Commission Approval for Opdivo with Chemotherapy as Neoadjuva...
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Ono Pharmaceutical that are available to investors today. That information is available publicly through Ono media outlets and privately through word of mouth or via Ono internal channels. However, regardless of the origin, that massive amount of Ono data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Ono Pharmaceutical news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Ono Pharmaceutical relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Ono Pharmaceutical's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Ono Pharmaceutical alpha.

Ono Pharmaceutical Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Complementary Tools for Ono Pink Sheet analysis

When running Ono Pharmaceutical's price analysis, check to measure Ono Pharmaceutical's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Ono Pharmaceutical is operating at the current time. Most of Ono Pharmaceutical's value examination focuses on studying past and present price action to predict the probability of Ono Pharmaceutical's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Ono Pharmaceutical's price. Additionally, you may evaluate how the addition of Ono Pharmaceutical to your portfolios can decrease your overall portfolio volatility.
Idea Breakdown
Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Top Crypto Exchanges
Search and analyze digital assets across top global cryptocurrency exchanges
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios
Analyst Advice
Analyst recommendations and target price estimates broken down by several categories
Companies Directory
Evaluate performance of over 100,000 Stocks, Funds, and ETFs against different fundamentals
Bollinger Bands
Use Bollinger Bands indicator to analyze target price for a given investing horizon
Equity Valuation
Check real value of public entities based on technical and fundamental data